MPEG1/perforin-2 mutations in human pulmonary nontuberculous mycobacterial infections

  • JCI Insight. 2017 Apr 20;2(8):e89635. doi: 10.1172/jci.insight.89635.
Ryan M McCormack  1 ,  Eva P Szymanski  2 ,  Amy P Hsu  2 ,  Elena Perez  1 ,  Kenneth N Olivier  3 ,  Eva Fisher  1 ,  E Brook Goodhew  1 ,  Eckhard R Podack  1 ,  Steven M Holland  2
Affiliations
  • 1. Department of Microbiology and Immunology, University of Miami School of Medicine, Miami, Florida, USA.
  • 2. Laboratory of Clinical Infectious Diseases, NIAID, NIH.
  • 3. Cardiovascular and Pulmonary Branch, NHLBI, NIH, Bethesda, Maryland, USA.
Abstract

Perforin-2 is a highly conserved pore-forming protein encoded by macrophage expressed gene 1 (MPEG1). A number of studies have shown that Perforin-2-deficient mice are unable to survive following a Bacterial challenge that is nonlethal in WT mice. There is also recent evidence that Mpeg1+/- heterozygous mice display an intermediate killing ability compared with Mpeg1 WT and Mpeg1-/- mice. Despite these in vivo findings, to date, no perforin-2 deficiencies have been associated with human disease. Here, we report four patients with persistent nontuberculous mycobacterial Infection who had heterozygous MPEG1 mutations. In vitro, neutrophils, Macrophages, and B cells from these patients were unable to kill Mycobacterium avium as efficiently as normal controls. CRISPR mutagenesis validated the deleterious Antibacterial activity of these mutations. These data suggest that perforin-2 haploinsufficiency may contribute to human susceptibility to infections with intracellular bacteria.

Keywords
Genetics; Infectious disease.